{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:23:47Z","timestamp":1790619827160,"version":"4.1.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Drug Applied Research Center","award":["77698"],"award-info":[{"award-number":["77698"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53415-5","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:07:02Z","timestamp":1779091622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational design and immunoinformatics validation of a T cell multi-epitope vaccine targeting glioblastoma stem cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Reza","family":"Salahlou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safar","family":"Farajnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Bargahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Rahbarnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Kamalkazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"53415_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13287-021-02231-x","volume":"12","author":"ALV Alves","year":"2021","unstructured":"Alves, A. L. V. et al. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Stem Cell. Res. Ther. 12, 206. https:\/\/doi.org\/10.1186\/s13287-021-02231-x (2021).","journal-title":"Stem Cell. Res. Ther."},{"key":"53415_CR2","doi-asserted-by":"publisher","unstructured":"Sloan, A. R., Silver, D. J., Kint, S., Gallo, M. & Lathia, J. D. Cancer stem cell hypothesis 2.0 in glioblastoma: where are we now and where are we going? Neuro Oncol  26, 785\u2009\u2013\u200995.  https:\/\/doi.org\/10.1093\/neuonc\/noae011 (2024).","DOI":"10.1093\/neuonc\/noae011"},{"key":"53415_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10555-024-10183-w","volume":"43","author":"J Hawly","year":"2024","unstructured":"Hawly, J., Murcar, M. G., Schcolnik-Cabrera, A. & Issa, M. E. Glioblastoma stem cell metabolism and immunity. Cancer Metastasis Rev. 43, 1015\u20131035. https:\/\/doi.org\/10.1007\/s10555-024-10183-w (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"53415_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13041-025-01221-x","volume":"18","author":"R Salahlou","year":"2025","unstructured":"Salahlou, R., Farajnia, S., Alizadeh, E. & Dastmalchi, S. Recent developments in peptide vaccines against Glioblastoma, a review and update. Mol. Brain. 18, 50. https:\/\/doi.org\/10.1186\/s13041-025-01221-x (2025).","journal-title":"Mol. Brain"},{"key":"53415_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12245-025-00921-4","volume":"18","author":"O Uwishema","year":"2025","unstructured":"Uwishema, O. et al. Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions. Int. J. Emerg. Med. 18, 144. https:\/\/doi.org\/10.1186\/s12245-025-00921-4 (2025).","journal-title":"Int. J. Emerg. Med."},{"key":"53415_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen, P. Y. et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 22, 1073\u20131113. https:\/\/doi.org\/10.1093\/neuonc\/noaa106 (2020).","journal-title":"Neuro Oncol."},{"key":"53415_CR7","doi-asserted-by":"publisher","first-page":"1210044","DOI":"10.3389\/fimmu.2023.1210044","volume":"14","author":"L Buonaguro","year":"2023","unstructured":"Buonaguro, L. & Tagliamonte, M. Peptide-based vaccine for cancer therapies. Front. Immunol. 14, 1210044. https:\/\/doi.org\/10.3389\/fimmu.2023.1210044 (2023).","journal-title":"Front. Immunol."},{"key":"53415_CR8","doi-asserted-by":"publisher","first-page":"701291","DOI":"10.3389\/fonc.2021.701291","volume":"11","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. Targeting glioblastoma stem cells: a review on biomarkers, signal pathways and targeted therapy.. Front. Oncol. 11, 701291. https:\/\/doi.org\/10.3389\/fonc.2021.701291 (2021).","journal-title":"Front. Oncol."},{"key":"53415_CR9","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1038\/onc.2011.634","volume":"31","author":"CH Yoon","year":"2012","unstructured":"Yoon, C. H. et al. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene 31, 4655\u20134666. https:\/\/doi.org\/10.1038\/onc.2011.634 (2012).","journal-title":"Oncogene"},{"key":"53415_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2119\/molmed.2010.00062","volume":"17","author":"IV Ulasov","year":"2011","unstructured":"Ulasov, I. V., Nandi, S., Dey, M., Sonabend, A. M. & Lesniak, M. S. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol. Med. 17, 103\u2013112. https:\/\/doi.org\/10.2119\/molmed.2010.00062 (2011).","journal-title":"Mol. Med."},{"key":"53415_CR11","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang, P., Wan, W. W., Xiong, S. L., Feng, H. & Wu, N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell. Death Discov. 3, 16105. https:\/\/doi.org\/10.1038\/cddiscovery.2016.105 (2017).","journal-title":"Cell. Death Discov"},{"key":"53415_CR12","doi-asserted-by":"publisher","unstructured":"Hassn Mesrati, M., Behrooz, A. B. & Syahir, A. Y. A. A. Understanding glioblastoma biomarkers: knocking a mountain with a hammer. Cells  2020,  9. https:\/\/doi.org\/10.3390\/cells9051236 (2020).","DOI":"10.3390\/cells9051236"},{"key":"53415_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12935-020-01696-9","volume":"20","author":"AA Yarmishyn","year":"2020","unstructured":"Yarmishyn, A. A. et al. Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1. Cancer Cell. Int. 20, 597. https:\/\/doi.org\/10.1186\/s12935-020-01696-9 (2020).","journal-title":"Cancer Cell. Int."},{"key":"53415_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-9966-27-85","volume":"27","author":"M Zhang","year":"2008","unstructured":"Zhang, M. et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J. Exp. Clin. Cancer Res. 27, 85. https:\/\/doi.org\/10.1186\/1756-9966-27-85 (2008).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"53415_CR15","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1038\/s41467-025-58366-5","volume":"16","author":"C Lu","year":"2025","unstructured":"Lu, C. et al. Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression. Nat. Commun. 16, 2974. https:\/\/doi.org\/10.1038\/s41467-025-58366-5 (2025).","journal-title":"Nat. Commun."},{"key":"53415_CR16","doi-asserted-by":"publisher","unstructured":"Salvato, I. & Marchini, A. Immunotherapeutic strategies for the treatment of glioblastoma: current challenges and future perspectives. Cancers (Basel). 16, 896.  https:\/\/doi.org\/10.3390\/cancers16071276 (2024).","DOI":"10.3390\/cancers16071276"},{"key":"53415_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.omto.2020.06.019","volume":"18","author":"ASS Do","year":"2020","unstructured":"Do, A. S. S. et al. CD133 mRNA-loaded dendritic cell vaccination abrogates glioma stem cell propagation in humanized glioblastoma mouse model. Mol. Ther. Oncolytics. 18, 295\u2013303. https:\/\/doi.org\/10.1016\/j.omto.2020.06.019 (2020).","journal-title":"Mol. Ther. Oncolytics"},{"key":"53415_CR18","doi-asserted-by":"publisher","unstructured":"Polakova, I., Duskova, M. & Smahel, M. Antitumor DNA vaccination against the Sox2 transcription factor. Int. J. Oncol. 45, 139\u2009\u2013146 https:\/\/doi.org\/10.3892\/ijo.2014.2402 (2014).","DOI":"10.3892\/ijo.2014.2402"},{"key":"53415_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1158\/0008-5472.Can-13-1942","volume":"74","author":"R Favaro","year":"2014","unstructured":"Favaro, R. et al. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res. 74, 1833\u20131844. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-1942 (2014).","journal-title":"Cancer Res."},{"key":"53415_CR20","doi-asserted-by":"publisher","unstructured":"Wei, Y. et al. Advances of computational methods enhance the development of multi-epitope vaccines. Brief. Bioinform.  26, 2563.  https:\/\/doi.org\/10.1093\/bib\/bbaf055 (2024).","DOI":"10.1093\/bib\/bbaf055"},{"key":"53415_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-025-04352-z","volume":"16","author":"J He","year":"2025","unstructured":"He, J., Yan, X. & Hu, S. Glioma stem cells: drivers of tumor progression and recurrence. Stem Cell. Res. Ther. 16, 293. https:\/\/doi.org\/10.1186\/s13287-025-04352-z (2025).","journal-title":"Stem Cell. Res. Ther."},{"key":"53415_CR22","doi-asserted-by":"publisher","unstructured":"Rodriguez, S. M. B. et al. Glioblastoma stem cells-useful tools in the battle against cancer. Int. J. Mol. Sci. 23, 986.  https:\/\/doi.org\/10.3390\/ijms23094602 (2022).","DOI":"10.3390\/ijms23094602"},{"key":"53415_CR23","doi-asserted-by":"publisher","first-page":"e0172791","DOI":"10.1371\/journal.pone.0172791","volume":"12","author":"DV Brown","year":"2017","unstructured":"Brown, D. V. et al. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PLoS One. 12, e0172791. https:\/\/doi.org\/10.1371\/journal.pone.0172791 (2017).","journal-title":"PLoS One"},{"key":"53415_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","volume":"33","author":"RC Gimple","year":"2019","unstructured":"Gimple, R. C., Bhargava, S., Dixit, D. & Rich, J. N. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 33, 591\u2013609. https:\/\/doi.org\/10.1101\/gad.324301.119 (2019).","journal-title":"Genes Dev."},{"key":"53415_CR25","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00432-021-03704-5","volume":"147","author":"M Rehfeld","year":"2021","unstructured":"Rehfeld, M. et al. Differential expression of stem cell markers in proliferating cells in glioma. J. Cancer Res. Clin. Oncol. 147, 2969\u20132982. https:\/\/doi.org\/10.1007\/s00432-021-03704-5 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"53415_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12935-025-03846-3","volume":"25","author":"K Hadiloo","year":"2025","unstructured":"Hadiloo, K., Mostanadi, P., Asadzadeh, A., Taremi, S. & Esmaeilzadeh, A. Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions. Cancer Cell. Int. 25, 289. https:\/\/doi.org\/10.1186\/s12935-025-03846-3 (2025).","journal-title":"Cancer Cell. Int."},{"key":"53415_CR27","doi-asserted-by":"publisher","unstructured":"Obrador, E. et al. Glioblastoma therapy: past, present and future. Int. J. Mol. Sci. 25, 98.  https:\/\/doi.org\/10.3390\/ijms25052529 (2024).","DOI":"10.3390\/ijms25052529"},{"key":"53415_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/cncr.25581","volume":"117","author":"R Pallini","year":"2011","unstructured":"Pallini, R. et al. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 117, 162\u2013174. https:\/\/doi.org\/10.1002\/cncr.25581 (2011).","journal-title":"Cancer"},{"key":"53415_CR29","doi-asserted-by":"publisher","first-page":"649338","DOI":"10.3389\/fonc.2021.649338","volume":"11","author":"T Khan","year":"2021","unstructured":"Khan, T. & Cabral, H. Abnormal glycosylation of cancer stem cells and targeting strategies. Front. Oncol. 11, 649338. https:\/\/doi.org\/10.3389\/fonc.2021.649338 (2021).","journal-title":"Front. Oncol."},{"key":"53415_CR30","doi-asserted-by":"publisher","first-page":"217541","DOI":"10.1016\/j.canlet.2025.217541","volume":"614","author":"Y Zhai","year":"2025","unstructured":"Zhai, Y. et al. The development and potent antitumor efficacy of CD44\/CD133 dual-targeting IL7R\u03b1-armored CAR-T cells against glioblastoma. Cancer Lett. 614, 217541. https:\/\/doi.org\/10.1016\/j.canlet.2025.217541 (2025).","journal-title":"Cancer Lett."},{"key":"53415_CR31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203\u20131217. https:\/\/doi.org\/10.1101\/gad.261982.115 (2015).","journal-title":"Genes Dev."},{"key":"53415_CR32","doi-asserted-by":"publisher","first-page":"615704","DOI":"10.3389\/fonc.2021.615704","volume":"11","author":"K Piper","year":"2021","unstructured":"Piper, K., DePledge, L., Karsy, M. & Cobbs, C. Glioma stem cells as immunotherapeutic targets: advancements and challenges. Front. Oncol. 11, 615704. https:\/\/doi.org\/10.3389\/fonc.2021.615704 (2021).","journal-title":"Front. Oncol."},{"key":"53415_CR33","doi-asserted-by":"publisher","first-page":"696791","DOI":"10.3389\/fimmu.2021.696791","volume":"12","author":"AJ Stephens","year":"2021","unstructured":"Stephens, A. J., Burgess-Brown, N. A. & Jiang, S. Beyond just peptide antigens: the complex world of peptide-based cancer vaccines. Front. Immunol. 12, 696791. https:\/\/doi.org\/10.3389\/fimmu.2021.696791 (2021).","journal-title":"Front. Immunol."},{"key":"53415_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","volume":"18","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y., Wei, Y., Tian, X. & Wei, X. Cancer vaccines: current status and future directions. J. Hematol. Oncol. 18, 18. https:\/\/doi.org\/10.1186\/s13045-025-01670-w (2025).","journal-title":"J. Hematol. Oncol."},{"key":"53415_CR35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00262-021-03129-6","volume":"71","author":"F Liao","year":"2022","unstructured":"Liao, F. et al. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells. Cancer Immunol. Immunother. 71, 1959\u20131973. https:\/\/doi.org\/10.1007\/s00262-021-03129-6 (2022).","journal-title":"Cancer Immunol. Immunother"},{"key":"53415_CR36","doi-asserted-by":"publisher","first-page":"1458449","DOI":"10.3389\/fonc.2024.1458449","volume":"14","author":"S Jung","year":"2024","unstructured":"Jung, S. et al. AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients. Front. Oncol. 14, 1458449. https:\/\/doi.org\/10.3389\/fonc.2024.1458449 (2024).","journal-title":"Front. Oncol."},{"key":"53415_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/07391102.2021.2020166","volume":"41","author":"SAH Mohammadzadeh Hosseini Moghri","year":"2023","unstructured":"Mohammadzadeh Hosseini Moghri, S. A. H., Mahmoodi Chalbatani, G., Ranjbar, M., Raposo, C. & Abbasian, A. CD171 multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma. J. Biomol. Struct. Dyn. 41, 1028\u20131040. https:\/\/doi.org\/10.1080\/07391102.2021.2020166 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"53415_CR38","doi-asserted-by":"publisher","unstructured":"Abd-Aziz, N. & Poh, C. L. Development of peptide-based vaccines for cancer. J Oncol 2022, 9749363.  https:\/\/doi.org\/10.1155\/2022\/9749363 (2022).","DOI":"10.1155\/2022\/9749363"},{"key":"53415_CR39","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1158\/1078-0432.Ccr-12-2861","volume":"19","author":"JT Yeung","year":"2013","unstructured":"Yeung, J. T. et al. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma. Clin. Cancer Res. 19, 1816\u20131826. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2861 (2013).","journal-title":"Clin. Cancer Res."},{"key":"53415_CR40","doi-asserted-by":"publisher","unstructured":"Becker, A. P., Sells, B. E., Haque, S. J. & Chakravarti, A. Tumor heterogeneity in Gglioblastomas: from light microscopy to molecular pathology. Cancers (Basel) 2021,  13.  https:\/\/doi.org\/10.3390\/cancers13040761 (2021).","DOI":"10.3390\/cancers13040761"},{"key":"53415_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omto.2021.10.003","volume":"23","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Mycobacterium tuberculosis Rv3628 isan effective adjuvant via activationof dendritic cells for cancer immunotherapy. Mol. Ther. Oncolytics. 23, 288\u2013302. https:\/\/doi.org\/10.1016\/j.omto.2021.10.003 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"53415_CR42","doi-asserted-by":"publisher","first-page":"24962","DOI":"10.18632\/oncotarget.8771","volume":"7","author":"WS Kim","year":"2016","unstructured":"Kim, W. S. et al. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain. Oncotarget 7, 24962\u201324982. https:\/\/doi.org\/10.18632\/oncotarget.8771 (2016).","journal-title":"Oncotarget"},{"key":"53415_CR43","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558. https:\/\/doi.org\/10.1038\/s41577-018-0029-z (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"53415_CR44","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1073\/pnas.89.13.6065","volume":"89","author":"CS Hsieh","year":"1992","unstructured":"Hsieh, C. S., Heimberger, A. B., Gold, J. S., O\u2019Garra, A. & Murphy, K. M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. U S A. 89, 6065\u20136069. https:\/\/doi.org\/10.1073\/pnas.89.13.6065 (1992).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"53415_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal. Transduct. Target. Ther. 8, 283. https:\/\/doi.org\/10.1038\/s41392-023-01557-7 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"53415_CR46","doi-asserted-by":"publisher","first-page":"598160","DOI":"10.3389\/fchem.2020.598160","volume":"8","author":"T Abdullah","year":"2020","unstructured":"Abdullah, T. et al. Supramolecular self-assembled peptide-based vaccines: current state and future perspectives. Front. Chem. 8, 598160. https:\/\/doi.org\/10.3389\/fchem.2020.598160 (2020).","journal-title":"Front. Chem."},{"key":"53415_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10989-024-10620-y","volume":"30","author":"EG Ashkani","year":"2024","unstructured":"Ashkani, E. G. et al. Stability of multi-peptide vaccines in conditions enabling accessibility in limited resource settings. Int. J. Pept. Res. Ther. 30, 42 (2024).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"53415_CR48","doi-asserted-by":"publisher","unstructured":"Caporale, A., Adorinni, S., Lamba, D. & Saviano, M. Peptide-protein interactions: from drug design to supramolecular biomaterials. Molecules 26, 1452.  https:\/\/doi.org\/10.3390\/molecules26051219 (2021).","DOI":"10.3390\/molecules26051219"},{"key":"53415_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmolb.2015.00020","volume":"2","author":"P Craveur","year":"2015","unstructured":"Craveur, P. et al. Protein flexibility in the light of structural alphabets. Front. Mol. Biosci. 2, 20. https:\/\/doi.org\/10.3389\/fmolb.2015.00020 (2015).","journal-title":"Front. Mol. Biosci."},{"key":"53415_CR50","doi-asserted-by":"publisher","unstructured":"Nouri, Y., Weinkove, R. & Perret, R. T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells. J. Immunother. Cancer  9, 896.  https:\/\/doi.org\/10.1136\/jitc-2021-003065 (2021).","DOI":"10.1136\/jitc-2021-003065"},{"key":"53415_CR51","doi-asserted-by":"publisher","first-page":"1227833","DOI":"10.3389\/fimmu.2023.1227833","volume":"14","author":"S Chakraborty","year":"2023","unstructured":"Chakraborty, S. et al. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. Front. Immunol. 14, 1227833. https:\/\/doi.org\/10.3389\/fimmu.2023.1227833 (2023).","journal-title":"Front. Immunol."},{"key":"53415_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fimmu.2017.00158","volume":"8","author":"X Guo","year":"2017","unstructured":"Guo, X. et al. The novel toll-like receptor 2 agonist SUP3 enhances antigen presentation and T cell activation by dendritic cells. Front. Immunol. 8, 158. https:\/\/doi.org\/10.3389\/fimmu.2017.00158 (2017).","journal-title":"Front. Immunol."},{"key":"53415_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","volume":"9","author":"LM Liau","year":"2023","unstructured":"Liau, L. M. et al. Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial. JAMA Oncol. 9, 112\u2013121. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5370 (2023).","journal-title":"JAMA Oncol."},{"key":"53415_CR54","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1200\/jco.22.00996","volume":"41","author":"MS Ahluwalia","year":"2023","unstructured":"Ahluwalia, M. S. et al. Phase IIa study of SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma. J. Clin. Oncol. 41, 1453\u20131465. https:\/\/doi.org\/10.1200\/jco.22.00996 (2023).","journal-title":"J. Clin. Oncol."},{"key":"53415_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie, N. et al. Neoantigens: promising targets for cancer therapy. Signal. Transduct. Target. Ther. 8, 9. https:\/\/doi.org\/10.1038\/s41392-022-01270-x (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"53415_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrc.2016.154","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Johnson, B. A., Lutz, E. R., Laheru, D. A., Jaffee, E. M. & rd,, Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer. 17, 209\u2013222. https:\/\/doi.org\/10.1038\/nrc.2016.154 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"53415_CR57","doi-asserted-by":"publisher","unstructured":"Xing, Y. & Hogquist, K. A. T-cell tolerance: central and peripheral. Cold Spring Harb. Perspect Biol. 2012, 4. https:\/\/doi.org\/10.1101\/cshperspect.a006957   (2012).","DOI":"10.1101\/cshperspect.a006957"},{"key":"53415_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/0008-5472.Can-14-2538","volume":"75","author":"A Makkouk","year":"2015","unstructured":"Makkouk, A. & Weiner, G. J. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge. Cancer Res. 75, 5\u201310. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-2538 (2015).","journal-title":"Cancer Res."},{"key":"53415_CR59","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhou, F., Ali, H., Lathia, J. D. & Chen, P. Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell. Mol. Immunol. 21, 1354\u20131375. https:\/\/doi.org\/10.1038\/s41423-024-01226-x (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"53415_CR60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s10147-025-02777-3","volume":"30","author":"D Kawauchi","year":"2025","unstructured":"Kawauchi, D. & Narita, Y. The curse of blood-brain barrier and blood-tumor barrier in malignant brain tumor treatment. Int. J. Clin. Oncol. 30, 1276\u20131286. https:\/\/doi.org\/10.1007\/s10147-025-02777-3 (2025).","journal-title":"Int. J. Clin. Oncol."},{"key":"53415_CR61","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.immuni.2025.04.017","volume":"58","author":"KW Song","year":"2025","unstructured":"Song, K. W., Lim, M. & Monje, M. Complex neural-immune interactions shape glioma immunotherapy. Immunity 58, 1140\u20131160. https:\/\/doi.org\/10.1016\/j.immuni.2025.04.017 (2025).","journal-title":"Immunity"},{"key":"53415_CR62","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/1878-0261.13657","volume":"18","author":"G Solomou","year":"2024","unstructured":"Solomou, G., Young, A. M. H. & Bulstrode, H. Microglia and macrophages in glioblastoma: landscapes and treatment directions. Mol. Oncol. 18, 2906\u20132926. https:\/\/doi.org\/10.1002\/1878-0261.13657 (2024).","journal-title":"Mol. Oncol."},{"key":"53415_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00262-025-04226-6","volume":"75","author":"M Levite","year":"2026","unstructured":"Levite, M., Ilouz, N., Galun, E. & Shoshan, Y. Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest. Cancer Immunol. Immunother. 75, 54. https:\/\/doi.org\/10.1007\/s00262-025-04226-6 (2026).","journal-title":"Cancer Immunol. Immunother"},{"key":"53415_CR64","doi-asserted-by":"publisher","unstructured":"Qin, R. et al. Multiomics investigation of exhausted T cells in glioblastoma tumor microenvironment: CCL5 as a prognostic and therapeutic target. Int. J. Mol. Sci. 26, 896.  https:\/\/doi.org\/10.3390\/ijms26209920 (2025).","DOI":"10.3390\/ijms26209920"},{"key":"53415_CR65","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/s41388-019-1045-6","volume":"39","author":"W Yang","year":"2020","unstructured":"Yang, W., Li, Y., Gao, R., Xiu, Z. & Sun, T. MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/\u03b2-catenin signaling pathway. Oncogene 39, 1098\u20131111. https:\/\/doi.org\/10.1038\/s41388-019-1045-6 (2020).","journal-title":"Oncogene"},{"key":"53415_CR66","doi-asserted-by":"publisher","unstructured":"Liu, Y., Ali, H., Khan, F., Pang, L. & Chen, P. Epigenetic regulation of tumor-immune symbiosis in glioma. Trends Mol. Med. 30, 429\u2009\u2013\u2009424. https:\/\/doi.org\/10.1016\/j.molmed.2024.02.004 (2024).","DOI":"10.1016\/j.molmed.2024.02.004"},{"key":"53415_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccell.2021.02.012","volume":"39","author":"MS Graham","year":"2021","unstructured":"Graham, M. S. & Mellinghoff, I. K. Meningeal lymphatics prime tumor immunity in glioblastoma. Cancer Cell. 39, 304\u2013306. https:\/\/doi.org\/10.1016\/j.ccell.2021.02.012 (2021).","journal-title":"Cancer Cell."},{"key":"53415_CR68","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1038\/s41467-024-49989-1","volume":"15","author":"CA von Roemeling","year":"2024","unstructured":"von Roemeling, C. A. et al. Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade. Nat. Commun. 15, 5871. https:\/\/doi.org\/10.1038\/s41467-024-49989-1 (2024).","journal-title":"Nat. Commun."},{"key":"53415_CR69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N Hilf","year":"2019","unstructured":"Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240\u2013245. https:\/\/doi.org\/10.1038\/s41586-018-0810-y (2019).","journal-title":"Nature"},{"key":"53415_CR70","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","volume":"565","author":"DB Keskin","year":"2019","unstructured":"Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature 565, 234\u2013239. https:\/\/doi.org\/10.1038\/s41586-018-0792-9 (2019).","journal-title":"Nature"},{"key":"53415_CR71","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701. https:\/\/doi.org\/10.1038\/s41586-019-1671-8 (2019).","journal-title":"Nature"},{"key":"53415_CR72","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nm.3105","volume":"19","author":"Y Hailemichael","year":"2013","unstructured":"Hailemichael, Y. et al. Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nat. Med. 19, 465\u2013472. https:\/\/doi.org\/10.1038\/nm.3105 (2013).","journal-title":"Nat. Med."},{"key":"53415_CR73","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.Ccr-08-0526","volume":"14","author":"WN Haining","year":"2008","unstructured":"Haining, W. N. et al. CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans. Clin. Cancer Res. 14, 5626\u20135634. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0526 (2008).","journal-title":"Clin. Cancer Res."},{"key":"53415_CR74","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1158\/0008-5472.Can-09-2019","volume":"69","author":"HI Cho","year":"2009","unstructured":"Cho, H. I. & Celis, E. Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res. 69, 9012\u20139019. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-2019 (2009).","journal-title":"Cancer Res."},{"key":"53415_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","volume":"13","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. cGAS-STING, an important pathway in cancer immunotherapy. J. Hematol. Oncol. 13, 81. https:\/\/doi.org\/10.1186\/s13045-020-00916-z (2020).","journal-title":"J. Hematol. Oncol."},{"key":"53415_CR76","doi-asserted-by":"publisher","first-page":"104963","DOI":"10.1016\/j.ebiom.2023.104963","volume":"100","author":"Z Xiong","year":"2024","unstructured":"Xiong, Z. et al. Glioblastoma vaccines: past, present, and opportunities. EBioMedicine 100, 104963. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104963 (2024).","journal-title":"EBioMedicine"},{"key":"53415_CR77","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jpha.2023.04.012","volume":"13","author":"P Zhu","year":"2023","unstructured":"Zhu, P. et al. Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C. J. Pharm. Anal. 13, 616\u2013624. https:\/\/doi.org\/10.1016\/j.jpha.2023.04.012 (2023).","journal-title":"J. Pharm. Anal."},{"key":"53415_CR78","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/jco.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang, F. F. et al. Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J. Clin. Oncol. 36, 1419\u20131427. https:\/\/doi.org\/10.1200\/jco.2017.75.8219 (2018).","journal-title":"J. Clin. Oncol."},{"key":"53415_CR79","doi-asserted-by":"publisher","unstructured":"UniProt. The Universal Protein Knowledgebase in 2023. Nucleic Acids Res  51, D523-d31. https:\/\/doi.org\/10.1093\/nar\/gkac1052 (2023).","DOI":"10.1093\/nar\/gkac1052"},{"key":"53415_CR80","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013w54. https:\/\/doi.org\/10.1093\/nar\/gkaa379 (2020).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4. https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinform."},{"key":"53415_CR82","doi-asserted-by":"publisher","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","volume":"9","author":"JJ Calis","year":"2013","unstructured":"Calis, J. J. et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput. Biol. 9, e1003266. https:\/\/doi.org\/10.1371\/journal.pcbi.1003266 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"53415_CR83","doi-asserted-by":"publisher","unstructured":"Paul, S., Sidney, J., Sette, A. & Peters, B.  TepiTool: a pipeline for computational prediction of T cell epitope candidates. Curr Protoc Immunol  114, 18.9.1-.9.24. https:\/\/doi.org\/10.1002\/cpim.12 (2016).","DOI":"10.1002\/cpim.12"},{"key":"53415_CR84","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang, P. et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinform. 11, 568. https:\/\/doi.org\/10.1186\/1471-2105-11-568 (2010).","journal-title":"BMC Bioinform."},{"key":"53415_CR85","doi-asserted-by":"publisher","first-page":"eadj6367","DOI":"10.1126\/sciadv.adj6367","volume":"9","author":"JB Nilsson","year":"2023","unstructured":"Nilsson, J. B. et al. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci. Adv. 9, eadj6367. https:\/\/doi.org\/10.1126\/sciadv.adj6367 (2023).","journal-title":"Sci. Adv."},{"key":"53415_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K., Vir, P. & Raghava, G. P. Designing of interferon-gamma inducing MHC class-II binders. Biol. Direct. 8, 30. https:\/\/doi.org\/10.1186\/1745-6150-8-30 (2013).","journal-title":"Biol. Direct"},{"key":"53415_CR87","doi-asserted-by":"publisher","unstructured":"Dhanda, S. K., Gupta, S., Vir, P. & Raghava, G. P. Prediction of IL4 inducing peptides. Clin. Dev. Immunol. 2013,  263952.   https:\/\/doi.org\/10.1155\/2013\/263952 (2013).","DOI":"10.1155\/2013\/263952"},{"key":"53415_CR88","doi-asserted-by":"publisher","unstructured":"Alspach, E., Lussier, D. M. & Schreiber, R. D. Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harb. Perspect. Biol. 11, 896.  https:\/\/doi.org\/10.1101\/cshperspect.a028480 (2019).","DOI":"10.1101\/cshperspect.a028480"},{"key":"53415_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5114\/ceji.2018.76273","volume":"44","author":"K Kwa\u015bniak","year":"2019","unstructured":"Kwa\u015bniak, K. et al. Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor \u03b2 on cancer cells. Cent. Eur. J. Immunol. 44, 190\u2013200. https:\/\/doi.org\/10.5114\/ceji.2018.76273 (2019).","journal-title":"Cent. Eur. J. Immunol."},{"key":"53415_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 7, 153. https:\/\/doi.org\/10.1186\/1471-2105-7-153 (2006).","journal-title":"BMC Bioinform."},{"key":"53415_CR91","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013w303. https:\/\/doi.org\/10.1093\/nar\/gky427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR92","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gky357","volume":"46","author":"P Zhou","year":"2018","unstructured":"Zhou, P., Jin, B., Li, H. & Huang, S. Y. HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm. Nucleic Acids Res. 46, W443\u2013w50. https:\/\/doi.org\/10.1093\/nar\/gky357 (2018).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR93","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/bioinformatics\/bty816","volume":"35","author":"A Vangone","year":"2019","unstructured":"Vangone, A. et al. Large-scale prediction of binding affinity in protein-small ligand complexes: the PRODIGY-LIG web server. Bioinformatics 35, 1585\u20131587. https:\/\/doi.org\/10.1093\/bioinformatics\/bty816 (2019).","journal-title":"Bioinformatics"},{"key":"53415_CR94","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"53415_CR95","doi-asserted-by":"publisher","first-page":"e40774","DOI":"10.1016\/j.heliyon.2024.e40774","volume":"10","author":"R Salahlou","year":"2024","unstructured":"Salahlou, R. et al. Design and in silico analysis of a novel peptide-based multiepitope vaccine against glioblastoma multiforme by targeting tumor-associated macrophage. Heliyon 10, e40774. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40774 (2024).","journal-title":"Heliyon"},{"key":"53415_CR96","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1080\/07391102.2022.2123395","volume":"41","author":"SAH Mohammadzadeh Hosseini Moghri","year":"2023","unstructured":"Mohammadzadeh Hosseini Moghri, S. A. H., Ranjbar, M., Hassannia, H. & Khakdan, F. In silico analysis of the conserved surface-exposed epitopes to design novel multiepitope peptide vaccine for all variants of the SARS-CoV-2. J. Biomol. Struct. Dyn. 41, 7603\u20137615. https:\/\/doi.org\/10.1080\/07391102.2022.2123395 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"53415_CR97","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1371\/journal.pmed.1000010","volume":"6","author":"JF Curtin","year":"2009","unstructured":"Curtin, J. F. et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 6, e10. https:\/\/doi.org\/10.1371\/journal.pmed.1000010 (2009).","journal-title":"PLoS Med."},{"key":"53415_CR98","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1158\/2326-6066.Cir-18-0020","volume":"6","author":"J Qian","year":"2018","unstructured":"Qian, J. et al. TLR2 promotes glioma immune evasion by downregulating MHC class II molecules in microglia. Cancer Immunol. Res. 6, 1220\u20131233. https:\/\/doi.org\/10.1158\/2326-6066.Cir-18-0020 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"53415_CR99","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13045-021-01191-2","volume":"14","author":"Y Xun","year":"2021","unstructured":"Xun, Y., Yang, H., Kaminska, B. & You, H. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma. J. Hematol. Oncol. 14, 176. https:\/\/doi.org\/10.1186\/s13045-021-01191-2 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"53415_CR100","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","volume":"15","author":"RG Everson","year":"2024","unstructured":"Everson, R. G. et al. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat. Commun. 15, 3882. https:\/\/doi.org\/10.1038\/s41467-024-48073-y (2024).","journal-title":"Nat. Commun."},{"key":"53415_CR101","doi-asserted-by":"publisher","unstructured":"Low, J. T. et al. Understanding and therapeutically exploiting cGAS\/STING signaling in glioblastoma. J. Clin. Invest. 134, 365.  https:\/\/doi.org\/10.1172\/jci163452 (2024).","DOI":"10.1172\/jci163452"},{"key":"53415_CR102","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1385\/1-59259-584-7:531","volume":"112","author":"MR Wilkins","year":"1999","unstructured":"Wilkins, M. R. et al. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol. 112, 531\u2013552. https:\/\/doi.org\/10.1385\/1-59259-584-7:531 (1999).","journal-title":"Methods Mol. Biol."},{"key":"53415_CR103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bioinformatics\/btaa1102","volume":"37","author":"J Hon","year":"2021","unstructured":"Hon, J. et al. SoluProt: prediction of soluble protein expression in Escherichia coli. Bioinformatics 37, 23\u201328. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1102 (2021).","journal-title":"Bioinformatics"},{"key":"53415_CR104","doi-asserted-by":"publisher","unstructured":"Sharma, N. et al. AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes. Brief. Bioinform. 22, 986.  https:\/\/doi.org\/10.1093\/bib\/bbaa294 (2021).","DOI":"10.1093\/bib\/bbaa294"},{"key":"53415_CR105","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2013a server for in silico prediction of allergens. J. Mol. Model. 20, 2278. https:\/\/doi.org\/10.1007\/s00894-014-2278-5 (2014).","journal-title":"J. Mol. Model."},{"key":"53415_CR106","doi-asserted-by":"publisher","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: an improved method for predicting toxicity of proteins. Brief. Bioinform. 23, 968.  https:\/\/doi.org\/10.1093\/bib\/bbac174 (2022).","DOI":"10.1093\/bib\/bbac174"},{"key":"53415_CR107","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","volume":"40","author":"F Teufel","year":"2022","unstructured":"Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40, 1023\u20131025. https:\/\/doi.org\/10.1038\/s41587-021-01156-3 (2022).","journal-title":"Nat. Biotechnol."},{"key":"53415_CR108","doi-asserted-by":"publisher","unstructured":"Hallgren, J. et al. DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks. bioRxiv.  https:\/\/doi.org\/10.1101\/2022.04.08.487609 (2022).","DOI":"10.1101\/2022.04.08.487609"},{"key":"53415_CR109","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16, 404\u2013405. https:\/\/doi.org\/10.1093\/bioinformatics\/16.4.404 (2000).","journal-title":"Bioinformatics"},{"key":"53415_CR110","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon, C. & Del\u00e9age, G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput. Appl. Biosci. 11, 681\u2013684. https:\/\/doi.org\/10.1093\/bioinformatics\/11.6.681 (1995).","journal-title":"Comput. Appl. Biosci."},{"key":"53415_CR111","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods. 19, 679\u2013682. https:\/\/doi.org\/10.1038\/s41592-022-01488-1 (2022).","journal-title":"Nat. Methods"},{"key":"53415_CR112","doi-asserted-by":"publisher","unstructured":"Heo, L., Park, H. &  Seok, C.  GalaxyRefine Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41, W384\u2013W388. https:\/\/doi.org\/10.1093\/nar\/gkt458 (2013).","DOI":"10.1093\/nar\/gkt458"},{"key":"53415_CR113","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2, 1511\u20131519. https:\/\/doi.org\/10.1002\/pro.5560020916 (1993).","journal-title":"Protein Sci."},{"key":"53415_CR114","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. Appl. Crystallogr. 26, 283\u2013291 (1993).","journal-title":"Appl. Crystallogr."},{"key":"53415_CR115","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/356083a0","volume":"356","author":"R L\u00fcthy","year":"1992","unstructured":"L\u00fcthy, R., Bowie, J. U. & Eisenberg, D. Assessment of protein models with three-dimensional profiles. Nature 356, 83\u201385. https:\/\/doi.org\/10.1038\/356083a0 (1992).","journal-title":"Nature"},{"key":"53415_CR116","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, W407\u2013W410. https:\/\/doi.org\/10.1093\/nar\/gkm290 (2007).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR117","doi-asserted-by":"publisher","first-page":"W95","DOI":"10.1093\/nar\/gkaf412","volume":"53","author":"K Wr\u00f3blewski","year":"2025","unstructured":"Wr\u00f3blewski, K., Zalewski, M., Kuriata, A. & Kmiecik, S. CABS-flex 3.0: an online tool for simulating protein structural flexibility and peptide modeling. Nucleic Acids Res. 53, W95\u2013w101. https:\/\/doi.org\/10.1093\/nar\/gkaf412 (2025).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR118","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 514. https:\/\/doi.org\/10.1186\/1471-2105-9-514 (2008).","journal-title":"BMC Bioinform."},{"key":"53415_CR119","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D. et al. The ClusPro web server for protein-protein docking. Nat. Protoc. 12, 255\u2013278. https:\/\/doi.org\/10.1038\/nprot.2016.169 (2017).","journal-title":"Nat. Protoc."},{"key":"53415_CR120","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M. & Vangone, A. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes. Bioinformatics 32, 3676\u20133678. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514 (2016).","journal-title":"Bioinformatics"},{"key":"53415_CR121","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382. https:\/\/doi.org\/10.1002\/pro.3943 (2021).","journal-title":"Protein Sci."},{"key":"53415_CR122","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski, R. A. et al. Structural summaries of PDB entries. Protein Sci. 27, 129\u2013134. https:\/\/doi.org\/10.1002\/pro.3289 (2018).","journal-title":"Protein Sci."},{"key":"53415_CR123","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R., Aliaga, J. I., Quintana-Ort\u00ed, E. S. & Chac\u00f3n, P. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 42, W271\u2013W276. https:\/\/doi.org\/10.1093\/nar\/gku339 (2014).","journal-title":"Nucleic Acids Res."},{"key":"53415_CR124","doi-asserted-by":"publisher","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX  1\u20132, 19\u201325.  https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"53415_CR125","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan, Y. et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999\u20132012. https:\/\/doi.org\/10.1002\/jcc.10349 (2003).","journal-title":"J. Comput. Chem."},{"key":"53415_CR126","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"53415_CR127","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 5, e9862. https:\/\/doi.org\/10.1371\/journal.pone.0009862 (2010).","journal-title":"PLoS One"},{"key":"53415_CR128","doi-asserted-by":"publisher","first-page":"111100","DOI":"10.1016\/j.compbiomed.2025.111100","volume":"197","author":"A Khalaj","year":"2025","unstructured":"Khalaj, A. & Moghri, S. Immunoinformatics design of multi-epitope vaccine candidates against ESKAPE pathogens as nosocomial infection. Comput. Biol. Med. 197, 111100. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111100 (2025).","journal-title":"Comput. Biol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53415-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:35:46Z","timestamp":1784241346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53415-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"22423"}}